Care patterns for older people receiving head and neck radiation
Part of Cancer, Ear, nose & throat, Lungs & breathing, Mouth & dental clinical trials.
This study looks at special ways of providing care for people age 65 and older with certain head-and-neck cancers when they receive radiation (with or without chemotherapy). It aims to understand how care should be organized to better support older patients during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 65 or older when you start (chemo-)radiation
- Your cancer is a squamous cell type in the mouth, throat (oropharynx/hypopharynx), or larynx
- Your treatment goal is the main/first treatment (not after-surgery “adjuvant” radiation)
- Your cancer was considered locally advanced, such as bigger tumor (T3–T4) and/or lymph node involvement (N+)
- Your cancer has not spread to distant parts of the body at the start (no M1 metastases)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adjusting the dose of chemotherapy and radiation for older adults (65+) with HPV-related throat cancer. The goal is to find a treatment that is effective but gentler on the body.
This study tests an approach called “adaptive radiotherapy,” where the radiation plan may be adjusted based on how your tumor and anatomy look during treatment. It is for adults with biopsy-proven oropharyngeal (throat) squamous cell carcinoma who are planning curative radiation, with or without chemotherapy.
This study tests a program that adds extra support (like nutrition, symptom management, and emotional care) early on for people with advanced head and neck cancer who are getting chemotherapy and radiation. The goal is to see if this extra care helps you feel better and handle treatment more easily.
This trial studies how to predict side effects (toxicity) in older adults (70+) with advanced head and neck cancer. It tests standard treatments like radiation, chemoradiation, or radiation with cetuximab and aims to help doctors tailor care to reduce harm.
This trial tests an oral (mouth) care program for people with head and neck cancer who are about to start full-dose, curative radiation. It may help protect your mouth and salivary glands during treatment.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
Hear when a new HNSCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.